Haemonetics Corporation (HAE)
USD 78.77
(-4.02%)
USD 78.77
(-4.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 695.08 Million USD | 30.65% |
| 2023 | 481.42 Million USD | -6.36% |
| 2022 | 514.09 Million USD | -0.23% |
| 2021 | 515.3 Million USD | 110.17% |
| 2020 | 245.18 Million USD | 35.63% |
| 2019 | 180.76 Million USD | 145.9% |
| 2018 | 73.51 Million USD | -58.01% |
| 2017 | 175.08 Million USD | -40.22% |
| 2016 | 292.87 Million USD | 9.6% |
| 2015 | 267.22 Million USD | 8.98% |
| 2014 | 245.21 Million USD | -18.53% |
| 2013 | 300.97 Million USD | 233.71% |
| 2012 | -225.09 Million USD | -17.34% |
| 2011 | -191.82 Million USD | -59.98% |
| 2010 | -119.91 Million USD | 20.42% |
| 2009 | -150.68 Million USD | -24.34% |
| 2008 | -121.19 Million USD | 39.51% |
| 2007 | -200.35 Million USD | 5.28% |
| 2006 | -211.51 Million USD | -51.11% |
| 2005 | -139.97 Million USD | -133.84% |
| 2004 | -59.85 Million USD | -388.72% |
| 2003 | 20.73 Million USD | -44.31% |
| 2002 | 37.23 Million USD | 31.66% |
| 2001 | 28.27 Million USD | 119.65% |
| 2000 | 12.87 Million USD | 359.79% |
| 1999 | 2.8 Million USD | -94.32% |
| 1998 | 49.3 Million USD | 132.55% |
| 1997 | 21.2 Million USD | 307.69% |
| 1996 | 5.2 Million USD | -82.19% |
| 1995 | 29.2 Million USD | 1636.84% |
| 1994 | -1.9 Million USD | -157.58% |
| 1993 | 3.3 Million USD | -84.43% |
| 1992 | 21.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 695.08 Million USD | 44.38% |
| 2024 Q2 | 411.22 Million USD | -14.19% |
| 2024 Q1 | 479.23 Million USD | -0.45% |
| 2024 Q3 | 676.6 Million USD | 64.54% |
| 2024 Q4 | 695.08 Million USD | 2.73% |
| 2023 Q4 | 481.42 Million USD | -11.3% |
| 2023 Q2 | 576.54 Million USD | 3.87% |
| 2023 Q3 | 542.77 Million USD | -5.86% |
| 2023 Q1 | 555.04 Million USD | 7.97% |
| 2023 FY | 481.42 Million USD | -6.36% |
| 2022 Q4 | 514.09 Million USD | -4.85% |
| 2022 Q2 | 588.35 Million USD | -3.69% |
| 2022 Q1 | 610.9 Million USD | 18.55% |
| 2022 FY | 514.09 Million USD | -0.23% |
| 2022 Q3 | 540.3 Million USD | -8.17% |
| 2021 FY | 515.3 Million USD | 110.17% |
| 2021 Q1 | 252.53 Million USD | 3.0% |
| 2021 Q2 | 184.84 Million USD | -26.8% |
| 2021 Q3 | 120.77 Million USD | -34.66% |
| 2021 Q4 | 515.3 Million USD | 326.67% |
| 2020 Q3 | 245.28 Million USD | -5.25% |
| 2020 Q2 | 258.88 Million USD | 5.47% |
| 2020 Q1 | 245.45 Million USD | 35.79% |
| 2020 FY | 245.18 Million USD | 35.63% |
| 2020 Q4 | 245.18 Million USD | -0.04% |
| 2019 Q4 | 180.76 Million USD | -4.33% |
| 2019 Q2 | 143.88 Million USD | -7.63% |
| 2019 FY | 180.76 Million USD | 145.9% |
| 2019 Q1 | 155.77 Million USD | 111.9% |
| 2019 Q3 | 188.94 Million USD | 31.31% |
| 2018 Q4 | 73.51 Million USD | 295.74% |
| 2018 Q1 | 131.3 Million USD | -25.0% |
| 2018 FY | 73.51 Million USD | -58.01% |
| 2018 Q2 | 82.98 Million USD | -36.8% |
| 2018 Q3 | 18.57 Million USD | -77.61% |
| 2017 Q1 | 281.46 Million USD | -3.9% |
| 2017 Q3 | 206.62 Million USD | -17.08% |
| 2017 Q2 | 249.18 Million USD | -11.47% |
| 2017 Q4 | 175.08 Million USD | -15.27% |
| 2017 FY | 175.08 Million USD | -40.22% |
| 2016 Q2 | 334.06 Million USD | 4.51% |
| 2016 Q1 | 319.64 Million USD | 19.61% |
| 2016 Q3 | 321.94 Million USD | -3.63% |
| 2016 Q4 | 292.87 Million USD | -9.03% |
| 2016 FY | 292.87 Million USD | 9.6% |
| 2015 Q4 | 267.22 Million USD | -11.97% |
| 2015 Q1 | 290.99 Million USD | 18.67% |
| 2015 Q2 | 299.93 Million USD | 3.07% |
| 2015 Q3 | 303.55 Million USD | 1.21% |
| 2015 FY | 267.22 Million USD | 8.98% |
| 2014 FY | 245.21 Million USD | -18.53% |
| 2014 Q4 | 245.21 Million USD | -8.97% |
| 2014 Q3 | 269.38 Million USD | -11.75% |
| 2014 Q2 | 305.25 Million USD | -2.86% |
| 2014 Q1 | 314.22 Million USD | 4.4% |
| 2013 Q3 | 289.26 Million USD | -1.81% |
| 2013 FY | 300.97 Million USD | 233.71% |
| 2013 Q4 | 300.97 Million USD | 4.05% |
| 2013 Q1 | -230.98 Million USD | -2.62% |
| 2013 Q2 | 294.6 Million USD | 227.54% |
| 2012 Q3 | -199.72 Million USD | -12.83% |
| 2012 FY | -225.09 Million USD | -17.34% |
| 2012 Q2 | -177 Million USD | 16.65% |
| 2012 Q1 | -212.37 Million USD | -10.71% |
| 2012 Q4 | -225.09 Million USD | -12.7% |
| 2011 Q3 | -157.1 Million USD | -58.81% |
| 2011 Q1 | -72.66 Million USD | 39.9% |
| 2011 FY | -191.82 Million USD | -59.98% |
| 2011 Q4 | -191.82 Million USD | -22.11% |
| 2011 Q2 | -98.92 Million USD | -36.14% |
| 2010 FY | -119.91 Million USD | 20.42% |
| 2010 Q4 | -120.91 Million USD | 18.9% |
| 2010 Q3 | -149.08 Million USD | 5.74% |
| 2010 Q2 | -158.16 Million USD | -4.43% |
| 2010 Q1 | -151.46 Million USD | -0.52% |
| 2009 Q4 | -150.68 Million USD | -30.61% |
| 2009 FY | -150.68 Million USD | -24.34% |
| 2009 Q3 | -115.36 Million USD | -18.23% |
| 2009 Q1 | -105.37 Million USD | 13.05% |
| 2009 Q2 | -97.57 Million USD | 7.4% |
| 2008 Q4 | -121.19 Million USD | -16.03% |
| 2008 FY | -121.19 Million USD | 39.51% |
| 2008 Q1 | -190.93 Million USD | 4.7% |
| 2008 Q2 | -130.7 Million USD | 31.54% |
| 2008 Q3 | -104.44 Million USD | 20.09% |
| 2007 Q1 | -224.97 Million USD | -6.36% |
| 2007 Q3 | -197.63 Million USD | 4.8% |
| 2007 FY | -200.35 Million USD | 5.28% |
| 2007 Q4 | -200.35 Million USD | -1.38% |
| 2007 Q2 | -207.58 Million USD | 7.73% |
| 2006 Q3 | -190.43 Million USD | -16.57% |
| 2006 FY | -211.51 Million USD | -51.11% |
| 2006 Q2 | -163.37 Million USD | -6.98% |
| 2006 Q1 | -152.7 Million USD | -9.1% |
| 2006 Q4 | -211.51 Million USD | -11.07% |
| 2005 FY | -139.97 Million USD | -133.84% |
| 2005 Q4 | -139.97 Million USD | -26.04% |
| 2005 Q1 | -74.38 Million USD | -24.27% |
| 2005 Q2 | -90.33 Million USD | -21.44% |
| 2005 Q3 | -111.05 Million USD | -22.94% |
| 2004 Q2 | 3 Million USD | -84.93% |
| 2004 FY | -59.85 Million USD | -388.72% |
| 2004 Q3 | -30.6 Million USD | -1118.16% |
| 2004 Q4 | -59.85 Million USD | -95.57% |
| 2004 Q1 | 19.94 Million USD | -3.8% |
| 2003 Q1 | 32.79 Million USD | -11.92% |
| 2003 Q3 | 26.93 Million USD | -23.64% |
| 2003 Q2 | 35.27 Million USD | 7.56% |
| 2003 FY | 20.73 Million USD | -44.31% |
| 2003 Q4 | 20.73 Million USD | -23.02% |
| 2002 Q2 | 22.63 Million USD | -34.85% |
| 2002 Q3 | 22.45 Million USD | -0.79% |
| 2002 Q1 | 34.74 Million USD | 22.88% |
| 2002 Q4 | 37.23 Million USD | 65.78% |
| 2002 FY | 37.23 Million USD | 31.66% |
| 2001 Q2 | 20.24 Million USD | 46.57% |
| 2001 Q1 | 13.81 Million USD | 7.29% |
| 2001 Q3 | 10.68 Million USD | -47.24% |
| 2001 FY | 28.27 Million USD | 119.65% |
| 2001 Q4 | 28.27 Million USD | 164.78% |
| 2000 Q4 | 12.87 Million USD | -58.87% |
| 2000 Q2 | 6.8 Million USD | -16.05% |
| 2000 Q3 | 31.3 Million USD | 360.29% |
| 2000 Q1 | 8.1 Million USD | 189.29% |
| 2000 FY | 12.87 Million USD | 359.79% |
| 1999 Q4 | 2.8 Million USD | -87.21% |
| 1999 Q1 | 47.2 Million USD | -4.26% |
| 1999 Q2 | 27 Million USD | -42.8% |
| 1999 Q3 | 21.9 Million USD | -18.89% |
| 1999 FY | 2.8 Million USD | -94.32% |
| 1998 FY | 49.3 Million USD | 132.55% |
| 1998 Q2 | 67 Million USD | 33.2% |
| 1998 Q3 | 65.4 Million USD | -2.39% |
| 1998 Q4 | 49.3 Million USD | -24.62% |
| 1998 Q1 | 50.3 Million USD | 137.26% |
| 1997 FY | 21.2 Million USD | 307.69% |
| 1997 Q4 | 21.2 Million USD | 146.51% |
| 1997 Q1 | 8.3 Million USD | 59.62% |
| 1997 Q2 | 9.4 Million USD | 13.25% |
| 1997 Q3 | 8.6 Million USD | -8.51% |
| 1996 FY | 5.2 Million USD | -82.19% |
| 1996 Q2 | 20.4 Million USD | -33.55% |
| 1996 Q1 | 30.7 Million USD | 5.14% |
| 1996 Q4 | 5.2 Million USD | 33.33% |
| 1996 Q3 | 3.9 Million USD | -80.88% |
| 1995 FY | 29.2 Million USD | 1636.84% |
| 1995 Q4 | 29.2 Million USD | 60.44% |
| 1995 Q1 | 7.6 Million USD | 500.0% |
| 1995 Q3 | 18.2 Million USD | 61.06% |
| 1995 Q2 | 11.3 Million USD | 48.68% |
| 1994 FY | -1.9 Million USD | -157.58% |
| 1994 Q2 | 7.4 Million USD | -14.94% |
| 1994 Q3 | - USD | -100.0% |
| 1994 Q4 | -1.9 Million USD | 0.0% |
| 1994 Q1 | 8.7 Million USD | 163.64% |
| 1993 Q3 | 7.1 Million USD | -56.44% |
| 1993 Q2 | 16.3 Million USD | -28.51% |
| 1993 Q4 | 3.3 Million USD | -53.52% |
| 1993 Q1 | 22.8 Million USD | 7.55% |
| 1993 FY | 3.3 Million USD | -84.43% |
| 1992 Q3 | 28.9 Million USD | 32.57% |
| 1992 FY | 21.2 Million USD | 0.0% |
| 1992 Q4 | 21.2 Million USD | -26.64% |
| 1992 Q1 | 17.6 Million USD | 0.0% |
| 1992 Q2 | 21.8 Million USD | 23.86% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alcon Inc. | 4.04 Billion USD | 82.836% |
| AptarGroup, Inc. | 961.03 Million USD | 27.673% |
| Baxter International Inc. | 11.16 Billion USD | 93.775% |
| Becton, Dickinson and Company | 14.46 Billion USD | 95.194% |
| Bausch + Lomb Corporation | 4.23 Billion USD | 83.572% |
| Envista Holdings Corp | 713.6 Million USD | 2.595% |
| ResMed Inc. | 635.57 Million USD | -9.363% |
| Teleflex Incorporated | 1.7 Billion USD | 59.197% |
| Warby Parker Inc. | -42.43 Million USD | 1737.92% |
| West Pharmaceutical Services, Inc. | -544.9 Million USD | 227.562% |